Sperm donors offered by CryoGam are selected according to a variety of strict criteria. Nearly 98% of donors who apply for the program are denied. Our rigorous selection process provides our patients with excellent donor sperm. The selection process includes:

 

• Three generation medical and genetic history

• Personal interview

• Genetic review analysis of donor's health history completed through certified genetic counselors.

• Psychological evalutation including Personality Assesment Inventory (PAI) assessment

• Physical examination completed by our board certified medical director

• Laboratory screening and testing completed through an FDA certified laboratory

• ​

Once a donor has been selected for the program, all frozen sperm samples are subject to a 180-day or more quarantine period prior to release. The donor must pass repeat screening and testing before CryoGam will release the samples for sale. This screening process helps to ensure sperm quality and to minimize the potential for transmitting infectious agents.

Donors complete the following testing prior to release of their sperm specimens:

 

Initial Testing:

• Complete semen analysis

• Blood Type and RH

• HIV-1 and HIV-2

• HIV-1 (NAT)

• HTLV-I and HTLV-II

• Syphilis

• Nisseria gonorrhea

• Chlamydia tracomatis

• Cytomegalovirus (CMV) Total (Reflexive IgG and IgM if necessary) - click here for CMV info

• Hepatitis B core antibody

• Hepatitis B surface antigen

• Hepatitis B (NAT) - This is currently not a FDA testing requirement; however, as of 1-12-12 it is part of the NAT testing kit used for donor testing.

• Hepatitis C antibody

• Hepatitis C (NAT)

• West Nile Virus (NAT) - Once between June 1st and October 31st (Beginning June 1st, 2017).

 

Repeat Testing Every Six-Months:

• HIV-1 and HIV-2

• HIV-1 (NAT)

• HTLV-I and HTLV-II

• Syphilis

• Nisseria gonorrhea

• Chlamydia tracomatis

• Cytomegalovirus (CMV) Total (reflexive IgG and IgM if necessary) - click here for CMV info

• Hepatitis B core antibody

• Hepatitis B surface antigen

• Hepatitis B (NAT) - this is currently not a FDA testing requirement; however, as of 1-12-12 it is part of the NAT testing kit used for donor testing.

• Hepatitis C antibody

• Hepatitis C (NAT)

• West Nile Virus (NAT) - If the collections fall within June 1st and October 31st (Beginning June 1st, 2017).

 

Genetic Testing: To reduce the likelihood of transmission of a genetic condition, CryoGam completes a thorough evaluation of the donor's medical history prior to accepting him into the donor program. Donors have are screened and tested based on available genetic testing at the time of donation and will vary between donor Levels. As genetic testing has advanced over time, donors are being screened and tested for more, so higher Level donors have completed more genetic testing. Please see each donor's Short Profile and/or Expanded Genetic Testing for more information on the genetic testing completed for each donor. If you have any questions about if a donor has been tested for specific condition, please reach out via email to info@cryogam.com so that we can assist you!

​

Level 2 donors have completed additional autosomal recessive genetic diseases testing, Level 3 and above donors have also completed chromosomal analysis (karyotype), and Level 4 & Level 5 donors have Expanded Genetic Testing performed testing for hundreds of autosomal recessive conditions. These Level 4 & 5 donors require Genetic Notification Authorization prior to purchase to ensure you are aware if the donor is a carrier for any autosomal recessive genetic conditions the donor has been tested for. 

 

Psychological Evalutaion: As part of our donor screening process, CryoGam donors undergo a psychological evaluation completed by a licensed mental health professional (MHP). During this clinical interview with a potential donor, the MHP gives the donor the Personality Assessment Inventory (PAI), which is a multi-question test that assists the MHP determine any personality of psychological traits the donor has that would interfere with the approval to be a donor. The MPH uses both results from the clinical interview and PAI to determine if the donor can be recommended to qualify as a donor. We work with qualified MHPs who follow ASRM guidelines and have extensive experience in third party reproduction and donor screening. Topics including review of the donation process and consideration of the experiences all individuals involved may have including the potential donor, intended parents, and donor conceived individuals. Our ultimate goal is that the potential donor fully understands the donation process and feels comfortable in becoming a sperm donor. Note: These evaluations began on Level 5 donors and have not been completed on lower level donors. 

*Please keep in mind that results of genetic screening are intended to be risk reducing, not risk eliminating. Genetic screening does not guarantee that offspring will be healthy or disease free.

​

 Have you set up your account with us yet? Click here for the necessary paperwork we will need prior to you placing an order.